Bertrand William C JR (CIK 1291937) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy ARDX (12,345 shares), Buy ARDX (26,455 shares), Sell ADAP (207,000 shares), Buy ARDX (19,390 shares), Buy ARDX (41,551 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | ARDELYX, INC. (ARDX) | Director | Buy | 12,345 | $0 |
| 2026-06-18 | ARDELYX, INC. (ARDX) | Director | Buy | 26,455 | $0 |
| 2025-08-29 | Adaptimmune Therapeutics PLC (ADAP) | Chief Operating Officer | Sell | 207,000 | $2,070 |
| 2025-06-23 | ARDELYX, INC. (ARDX) | Director | Buy | 19,390 | $0 |
| 2025-06-23 | ARDELYX, INC. (ARDX) | Director | Buy | 41,551 | $0 |
| 2025-01-17 | Adaptimmune Therapeutics PLC (ADAP) | Chief Operating Officer | Sell | 5,584 | $3,239 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Operating Officer | Sell | 4,268 | $2,518 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Operating Officer | Sell | 5,471 | $3,228 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Operating Officer | Sell | 9,803 | $5,588 |
Source: SEC Form 4 filings · as of 2026-06-18